| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |